Aurinia Pharmaceuticals Inc.·4

May 16, 5:04 PM ET

Bailey Jeffrey Allen 4

4 · Aurinia Pharmaceuticals Inc. · Filed May 16, 2025

Insider Transaction Report

Form 4
Period: 2025-05-16
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-05-16+37,48537,485 total
    Exercise: $8.15Exp: 2035-05-16Common Shares (37,485 underlying)
Footnotes (1)
  • [F1]The options shall vest one year from date of grant.

Documents

1 file
  • 4
    wk-form4_1747429452.xmlPrimary

    FORM 4